RASSF4 and gastric cancer: In GC, RASSF4 induces cell cycle G2/M arrest and enhances chemotherapy-induced apoptosis by activating the Chk2–p53 axis, effectively inhibiting proliferation and enhancing chemotherapy sensitivity, indicating that RASSF4 can be an important prognostic marker.